Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
38.99 USD | +2.55% |
|
-0.15% | -18.47% |
14/06 | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $45 From $48, Keeps Neutral Rating | MT |
14/06 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.47% | 344.1Cr | |
+15.67% | 12TCr | |
+20.45% | 11TCr | |
+8.24% | 2.28TCr | |
-20.25% | 2.07TCr | |
-16.19% | 1.65TCr | |
-13.80% | 1.64TCr | |
-44.35% | 1.58TCr | |
+2.38% | 1.35TCr | |
+67.29% | 1.17TCr |
- Stock Market
- Equities
- RARE Stock
- News Ultragenyx Pharmaceutical Inc.
- Ultragenyx Pharmaceutical Launches Equity Offering